Better predictive factors in endocrine-responsive breast cancer than the estrogen receptor itself

Int J Gynecol Cancer. 2006:16 Suppl 2:533-7. doi: 10.1111/j.1525-1438.2006.00690.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Erb-b2 Receptor Tyrosine Kinases / antagonists & inhibitors*
  • Estrogen Receptor Modulators / therapeutic use*
  • Female
  • Humans
  • Receptors, Estrogen / metabolism*
  • Receptors, Progesterone / metabolism

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor Modulators
  • Erb-b2 Receptor Tyrosine Kinases
  • Receptors, Estrogen
  • Receptors, Progesterone